The 53rd annual meeting of the American Association of Clinical Oncology officially kicked off Saturday, June 3. Over 38,000 oncology professionals and stakeholders in the future of cancer care from 120 nations are in attendance, making this the largest ASCO annual meeting to date.
A battle against the Emperor of All Maladies
The opening ceremony included guest speaker Dr. Siddhartha Mukherjee, assistant professor of medicine at Columbia University and author of the Pulitzer Prize winning book The Emperor of All Maladies: A Biography of Cancer and more recently, The Gene, An Intimate History. Dr. Mukherjee’s talk highlighted key tenants of modern medicine that have emerged in the 10 years since Emperor of All Maladies was published. In particular, that:
These tenets, he emphasized, are not yet generalizable across cancers, and there is much work to be done. Cancer medicine he said is in its adolescence and precision medicine is in its infancy. Dr. Mukherjee expressed profound optimism for the future but stressed responsibility of the oncology community to provide patients a different cancer experience by:
President’s Address on Making a Difference in Cancer Care:
The theme of this year’s meeting, which was hosted by outgoing ASCO president and BCRF investigator, Dr. Daniel Hayes is “Making a Difference in Cancer Care.” He emphasized ASCO’s commitment to empowering it’s 40,000 plus membership of cancer care professionals in addressing the challenges of the future.
In his president’s address, Dr. Hayes highlighted the advances in cancer care that he has witnessed over his 35 year career as a medical oncologist, noting that “We are curing some cancers, but we don’t cure enough of them fast enough.” He emphasized the following priorities in achieving his vision of making a difference in cancer care:
BCRF Highlights of the Day
Every year ASCO announces new inductees into the Fellows of ASCO. BCRF congratulates the following BCRF investigators and new FASCO Fellows:
Dr. Funmi Olopade was named the 2017 ASCO Humanitarian Award Recipient in recognition of her global work in health disparities and health equity and cancer prevention. In her award lecture, Dr. Olopade emphasized the need to diversify the workforce in order to achieve health equity and to democratize access to affordable health care globally.
Dr. Eric Winer is the recipient of the 2017 Gianni Bonadonna Breast Cancer Award. In his award lecture, he highlighted the tremendous progress in treatment of HER2-positive breast cancer which was a lethal disease prior to the development of trastuzumab (Herceptin®). In spite of the success in HER2-targeted therapies, he said, there are prevailing challenges including:
Stay tuned as we continue to provide updates from the ASCO Annual Meeting.
Please remember BCRF in your will planning. Learn More
Breast Cancer Research Foundation28 West 44th Street, Suite 609, New York, NY 10036
General Office: 646-497-2600 | Toll Free: email@example.com | BCRF is a 501 (c)(3) | EIN: 13-3727250